Scientists map pneumococcal strains in vietnamese kids to boost vaccine strategy
NCT ID NCT07562529
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 530 children aged 2 months to 5 years who are hospitalized with breathing problems in Vietnam. Researchers will check for pneumococcal bacteria in the nose and use advanced genetic testing to identify types and antibiotic resistance. The goal is to help improve vaccine policies and track resistance patterns.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide data to improve pneumococcal vaccine recommendations in Vietnam, potentially reducing severe infections in children.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly benefit participants, and findings may not apply to other regions or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 530 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children aged 2 months to 59 months hospitalized at Vietnam National Children's Hospital with acute respiratory symptoms
- Ages
-
2 months to 5 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 2 months to 59 months * Hospitalized with acute respiratory symptoms (≤14 days duration) * Parent or legal guardian provides written informed consent Acute respiratory symptoms defined as one or more of: * Cough * Rhinorrhea * Nasal obstruction * Sore throat * Tachypnea * Wheeze * Retraction Exclusion Criteria: * Confirmed pneumococcal infection within the past 30 days
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute respiratory symptoms are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Vietnam National Children's Hospital
Hanoi, 00000, Vietnam